Hemogenyx Pharmaceuticals Plc (HEMO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | -21 | 16 | -19 | 8 | 29 |
| Other Working Capital | -57 | -2 | -118 | -79 | 162 |
| Other Operating Activity | -1,720 | -1,214 | -1,216 | -382 | -469 |
| Operating Cash Flow | $-1,798 | $-1,200 | $-1,353 | $-453 | $-278 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -173 | -12 | -25 | -64 | N/A |
| Net Acquisitions | N/A | N/A | 0 | 1,099 | N/A |
| Other Investing Activity | 3 | 14 | 4 | 0 | 0 |
| Investing Cash Flow | $-170 | $2 | $-20 | $1,034 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 462 | 0 | 1,176 | N/A | N/A |
| Debt Repayment | N/A | N/A | 0 | -154 | N/A |
| Common Stock Issued | 3,183 | 0 | 5 | 2,000 | 0 |
| Other Financing Activity | -433 | -39 | 0 | -629 | 0 |
| Financing Cash Flow | $3,212 | $-39 | $1,181 | $1,217 | $0 |
| Exchange Rate Effect | 70 | -27 | 78 | -8 | N/A |
| Beginning Cash Position | 499 | 1,762 | 1,877 | 87 | 1,324 |
| End Cash Position | 1,812 | 499 | 1,762 | 1,877 | 1,046 |
| Net Cash Flow | $1,244 | $-1,237 | $-192 | $1,798 | $-278 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,798 | -1,200 | -1,353 | -453 | -278 |
| Capital Expenditure | -173 | -12 | -25 | -64 | N/A |
| Free Cash Flow | -1,971 | -1,212 | -1,377 | -517 | -278 |